vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $117.7M, roughly 1.0× Resolute Holdings Management, Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -1.5%, a 5.7% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $517.0K).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

CLB vs RHLD — Head-to-Head

Bigger by revenue
CLB
CLB
1.0× larger
CLB
$121.8M
$117.7M
RHLD
Higher net margin
CLB
CLB
5.7% more per $
CLB
4.2%
-1.5%
RHLD
More free cash flow
RHLD
RHLD
$188.7M more FCF
RHLD
$189.2M
$517.0K
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
RHLD
RHLD
Revenue
$121.8M
$117.7M
Net Profit
$5.1M
$-1.7M
Gross Margin
55.7%
Operating Margin
1.5%
30.2%
Net Margin
4.2%
-1.5%
Revenue YoY
-1.4%
Net Profit YoY
EPS (diluted)
$0.11
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
RHLD
RHLD
Q1 26
$121.8M
Q4 25
$138.3M
$117.7M
Q3 25
$134.5M
$120.9M
Q2 25
$130.2M
$119.6M
Q1 25
$123.6M
$103.9M
Q4 24
$129.2M
Q3 24
$134.4M
Q2 24
$130.6M
Net Profit
CLB
CLB
RHLD
RHLD
Q1 26
$5.1M
Q4 25
$4.9M
$-1.7M
Q3 25
$14.2M
$-231.0K
Q2 25
$10.6M
$-611.0K
Q1 25
$-154.0K
$-3.4M
Q4 24
$7.4M
Q3 24
$11.7M
Q2 24
$9.0M
Gross Margin
CLB
CLB
RHLD
RHLD
Q1 26
Q4 25
20.8%
55.7%
Q3 25
22.0%
59.0%
Q2 25
20.3%
57.5%
Q1 25
19.5%
52.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
RHLD
RHLD
Q1 26
1.5%
Q4 25
11.5%
30.2%
Q3 25
15.6%
34.3%
Q2 25
11.7%
34.0%
Q1 25
3.6%
24.7%
Q4 24
11.0%
Q3 24
14.7%
Q2 24
12.3%
Net Margin
CLB
CLB
RHLD
RHLD
Q1 26
4.2%
Q4 25
3.6%
-1.5%
Q3 25
10.6%
-0.2%
Q2 25
8.2%
-0.5%
Q1 25
-0.1%
-3.2%
Q4 24
5.7%
Q3 24
8.7%
Q2 24
6.9%
EPS (diluted)
CLB
CLB
RHLD
RHLD
Q1 26
$0.11
Q4 25
$0.11
$-0.20
Q3 25
$0.30
$-0.03
Q2 25
$0.22
$-0.07
Q1 25
$0.00
$-0.39
Q4 24
$0.15
Q3 24
$0.25
Q2 24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$22.8M
$205.5M
Total DebtLower is stronger
$169.8M
Stockholders' EquityBook value
$275.1M
$6.5M
Total Assets
$587.7M
$333.4M
Debt / EquityLower = less leverage
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
RHLD
RHLD
Q1 26
$22.8M
Q4 25
$22.7M
$205.5M
Q3 25
$25.6M
$148.0M
Q2 25
$31.2M
$99.9M
Q1 25
$22.1M
$71.0M
Q4 24
$19.2M
Q3 24
$21.5M
Q2 24
$17.7M
Total Debt
CLB
CLB
RHLD
RHLD
Q1 26
Q4 25
$110.3M
$169.8M
Q3 25
$114.1M
$173.4M
Q2 25
$124.6M
$177.1M
Q1 25
$124.4M
$180.7M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
RHLD
RHLD
Q1 26
$275.1M
Q4 25
$266.0M
$6.5M
Q3 25
$271.3M
$10.8M
Q2 25
$261.3M
$9.6M
Q1 25
$253.4M
$8.9M
Q4 24
$246.6M
Q3 24
$250.7M
Q2 24
$240.3M
Total Assets
CLB
CLB
RHLD
RHLD
Q1 26
$587.7M
Q4 25
$584.0M
$333.4M
Q3 25
$591.4M
$293.2M
Q2 25
$602.1M
$253.3M
Q1 25
$591.5M
$214.3M
Q4 24
$585.1M
Q3 24
$600.5M
Q2 24
$597.8M
Debt / Equity
CLB
CLB
RHLD
RHLD
Q1 26
Q4 25
0.41×
26.03×
Q3 25
0.42×
16.01×
Q2 25
0.48×
18.42×
Q1 25
0.49×
20.38×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
RHLD
RHLD
Operating Cash FlowLast quarter
$4.0M
$196.1M
Free Cash FlowOCF − Capex
$517.0K
$189.2M
FCF MarginFCF / Revenue
0.4%
160.8%
Capex IntensityCapex / Revenue
5.8%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
RHLD
RHLD
Q1 26
$4.0M
Q4 25
$7.9M
$196.1M
Q3 25
$8.5M
$59.6M
Q2 25
$13.9M
$48.9M
Q1 25
$6.7M
$18.4M
Q4 24
$20.6M
Q3 24
$13.1M
Q2 24
$17.1M
Free Cash Flow
CLB
CLB
RHLD
RHLD
Q1 26
$517.0K
Q4 25
$5.0M
$189.2M
Q3 25
$6.5M
$58.6M
Q2 25
$10.4M
$47.5M
Q1 25
$3.9M
$17.8M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
RHLD
RHLD
Q1 26
0.4%
Q4 25
3.6%
160.8%
Q3 25
4.8%
48.5%
Q2 25
8.0%
39.7%
Q1 25
3.1%
17.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
RHLD
RHLD
Q1 26
Q4 25
2.1%
5.8%
Q3 25
1.5%
0.8%
Q2 25
2.7%
1.2%
Q1 25
2.3%
0.6%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
RHLD
RHLD
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons